ovel transcranial electrical modulation for Major Depressive Disorder
- Conditions
- Major Depressive DisorderMental Health - Depression
- Registration Number
- ACTRN12621000498897
- Lead Sponsor
- Dirk De Ridder
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Participants with a diagnosis of MDD will be eligible to participate. To be included in the study, participants must meet all of the following inclusion criteria:
•Capable of understanding the study information and able to sign the informed consent form.
•Age between 18 to 60 years on the day of the consent.
•A score lower than three on the Maudsley Staging Method for treatment resistant depression.
Participants who meet any of the following conditions will be excluded:
•Other mental illness
•History of neurological diseases
•History of epilepsy or seizures
•History of substance abuse,
•Previous treatment with neuromodulation (e.g. Transcranial magnetic stimulation, electroconvulsive therapy, Neurofeedback, etc.)
•Dyslipidaemia
•Cognitive impairments (dementia, post-traumatic stress disorders, Alzheimer’s disease): A total score of 24 or below on Mini-Mental State Examination
•History of uncontrolled/untreated hypertension
•Presence of any pacemaker or defibrillator
•Presence of any electronic implants or metal implant in the body (particularly head and neck)
•Recent or current pregnancy
Note ~ Participants will be permitted to continue their medications for the duration of the trial, with the type and dosage of medication being recorded throughout the duration of the trial. However, participants with the intention of taking new medications in the next 2 months, will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method